§ 38-180. Definitions.

For purposes of this Division, the following definitions shall apply unless the context clearly indicates or requires different meaning:

A product containing a synthetic alternative drug means any product containing a synthetic cannabinoid, stimulant or psychedelic/hallucinogen, as those terms are defined herein such as, but not limited to, the examples of brand names or identifiers listed on Exhibit "A" attached hereto and incorporated herein.

Synthetic cannabinoid means any laboratory-created compound that functions similar to the active ingredient in marijuana, tetrahydrocannabinol (THC), including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog (including isomers, esters, ethers, salts, and salts of isomers) containing a cannabinoid receptor agonist, such as:

• JWH-007 (1-pentyl-2-methyl-3-(1-naphthoyl)indole)

• JWH-015 ((2-Methyl-1-propyl-1H-indol-3-y1)-1-naphthalenylmethanone)

• JWH-018 (1-pentyl-3-(1-naphthoyl)indole)

• JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole)

• JWH-073 (naphthalen-1-y1-(1-butylindol-3-yl)methanone)

• JWH-081 (4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone)

• JWH-098 (4-methoxynaphthalen-1-yl-(1-pentyl-2-methylindol-3-yl)methanone)

• JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole)

• JWH-164 (7-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone

• JWH-200 (1-(2-morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone)

• JWH-203 (2-(2-chlorophenyl)-1-(1-pentylindol-3-yl)ethanone

• JWH-210 (4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone

• JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole)

• JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole)

• JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole)

• HU-210 ((6aR, 10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol)

• HU-211 ((6aS, 10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol)

• HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol)

• HU-331 ((3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione)

• CP 55,940 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-5-(2-methyloctan-2-yl)phenol)

• CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol) and its homologues

• WIN 55,212-2 ((R)-(-)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de)-1,4-benzoxazin-6-yl]-1-nepthalenylmethanone)

• RCS-4 ((4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone)

• RCS-8 (1-(1-(2-cyclohexylethyl)-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone)

Synthetic stimulant means any compound that mimics the effects of any federally controlled Schedule I substance such as cathinone, methcathinone, MDMA and MDEA, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog (including salts, isomers, and salts of isomers) containing substances which have a stimulant effect on the central nervous system, such as:

• 3-Fluoromethcathinone

• 4-Fluoromethcathinone (other name: flephedrone)

• 3,4-Methylenedioxymethcathinone (other name: methylone, MDMC)

• 3,4-Methylenedioxypyrovalerone (other name: MDPV)

• 4-Methylmethcathinon (other names: mephedrone, 4-MMC)

• 4-Methoxymethcathinone (other names: methedrone, bk-PMMA, PMMC)

• 4-Ethylmethcathinone (other name: 4-EMC)

• Ethcathinone

• Beta-keto-N-methylbenzodioxyolylpropylamine (other names: butylone, bk-MBDB)

• Napthylpyrovalerone (other names: naphyrone, NRG-1)

• N,N-dimethylcathinone (other name: metamfepramone)

• Alpha-pyrrolidinopropiophenone (other name: alpha-PPP)

• 4-methoxy-alpha-pyrrolidinopropiophenone (other name: MOPPP)

• 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (other name: MDPPP)

• Alpha-pyrrolidinovalerophenone (other name: alpha-PVP)

• 6,7-kihydro-5H-indeno (5,6-d)-1,3-dioxal-6-amine) (other name: MDAI)

• Any compound that is structurally derived from 2-amino-1-phenyl-1-propanone by modification or substitution in any of the following ways:

• In the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;

• at the 3-position with an alkyl substituent;

• at the nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups;

• or by inclusion of the nitrogen atom in a cyclic structure.

Synthetic psychedelic/hallucinogen means any compound that mimics the effects of any federally controlled Schedule I substance, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog (including salts, isomers, esters, ethers and salts of isomers) containing substances which have a psychedelic/hallucinogenic effect on the central nervous system and/or brain, such as:

• 2-(2,5-Dimethoxy-4-ethyphenyl)ethanamine (2C-E);

• 2-(2.5-dimethoxy-4-methylphenyl)ethanamine (2C-D);

• 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);

• 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);

• 2-(4-(Ethylthio)-2,5-dimethoxyphenyl)ethanamine (2C-T-2);

• 2-(4-(Isopropylthio)-2,5-dimethoxyphenyl)ethanamine (2C-T-4);

• 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);

• 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);

• 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

(Ord. No. 1648, § 2, 12-8-2011)